Additive Effect of Oral Tetradecanoic Acid to Tamsulosin and Finasteride in a Benign Prostatic Hyperplasia Rat Model

Authors

  • Anup Patil

  • Dr. R.C. Doijad

  • Dr. P.V. Salve

  • A.A. Koparde

Keywords:

5alpha-reductase inhibitor, tetradecanoic acid, tamsulosin, finasteride

Abstract

We investigated the benefit of the tetradecanoic acid combined with tamsulosin and finasteride, in a benign prostatic hyperplasia (BPH) rat model. By bilateral orchiectomy under ketamine anesthesia Castration was performed. A rat model of BPH was established by daily intramuscular administration of testosterone propionate plus 17 alpha-estradiol for 8 weeks. For 4 weeks from week 6 to 9 post-surgery model rats were administered combinations of 20 mg/kg of tetradecanoic acid, 0.01 mg/kg tamsulosin and 1 mg/kg finasteride once daily by oral gavage. Body and genitourinary organ weights were recorded, serums were assayed for hormone concentrations, and tissues were subjected to histopathology Combined tetradecanoic acid, tamsulosin, and finasteride significantly decreased prostatic index, serum hormone levels, epithelial thickness, The 3-drug combination was more effective than any other combination or tetradecanoic acid alone. These results suggest that tetradecanoic acid addition to tamsulosin and finasteride may be beneficial for the treatment of BPH patients who do not respond to tamsulosin plus finasteride.

How to Cite

Additive Effect of Oral Tetradecanoic Acid to Tamsulosin and Finasteride in a Benign Prostatic Hyperplasia Rat Model. (2020). Global Journal of Medical Research, 20(21), 33-37. https://medicalresearchjournal.org/index.php/GJMR/article/view/2057

URL: https://medicalresearchjournal.org/index.php/GJMR/article/view/2057

References

Bob Djavan (2003) Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life Urology. 62(3), 6-14. https://doi.org/10.1016/s0090-4295(03)00589-2

Lee MY, Shin IS, Seo CS (2012) Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats Asian J Androl. 14(2), 320-324. https://doi.org/10.1038/aja.2011.166

Null- Sagnier, Gary MacFarlane, Pierre Teillac, Henry Botto, Francois Richard, Peter. Boyle (1995) Impact of symptoms of prostatism on level of bother and quality of life of men in the French community J Urol. 153(3), 669-673. https://doi.org/10.1016/s0022-5347(01)67681-x

Lee YJ, Lee JW, Park J (2016) Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea Investig Clin Urol. 57(6), 424. https://doi.org/10.4111/icu.2016.57.6.424

Veeresh Babu, S. Veeresh, B. Patil, A. Warke, Y. (2010) Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats Eur J Pharmacol. 626, 262-265.

Cho KS, Park CW, Kim CK (2013) Effects of Korean ginseng berry extract (GB0710) on penile erection: evidence from in vitro and in vivo studies Asian J Androl. 15(4), 503-507. https://doi.org/10.1038/aja.2013.49

Culley Carson, Roger Rittmaster (2003) The role of dihydrotestosterone in benign prostatic hyperplasia Urology. 61(4), 2-7. https://doi.org/10.1016/s0090-4295(03)00045-1

S. Fine, P. Ginsberg (2008) Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications J Am Osteopath Assoc. 108, 333-337.

E. Lee (2002) Comparison of tamsulosin and finasteride for lower urinary tract symptoms associated with benign prostatic hyperplasia in Korean patients J Int Med Res. 30(6), 584-590. https://doi.org/10.1177/147323000203000606

Roehrborn McConnell JD, Bautista OM, Dixon Andriole GL Jr, Kusek JW (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med. 349(25), 2387-2398. https://doi.org/10.1056/nejmoa030656

Akiyama K, Hora M, Tatemichi S (1999) KMD-3213, a Uroselective and Long-Acting α1a-Adrenoceptor Antagonist, Tested in a Novel Rat Model. 291(1), 81-91. https://doi.org/10.1016/s0022-3565(24)35074-8

Lee SW, Paick JS, Park HJ (2014) The efficacy and safety of tadalafil 5 mg once daily in Korean men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: an integrated analysis World J Men Health. 32(1), 28. https://doi.org/10.5534/wjmh.2014.32.1.28

Katsuyoshi Akiyama, Masachiyo Hora, Ryoichi Yamagishi, Makio Kitazawa (2002) Effects of KMD-3213, a Uroselective α1A-Adrenoceptor Antagonist, on the Tilt-Induced Blood Pressure Response in Normotensive Rats. 90(2), 131-137. https://doi.org/10.1254/jjp.90.131

Sung HH, Choo SH, Han DH (2015) Effect of the novel BKCa channel opener LDD175 on the modulation of corporal smooth muscle tone J Sex Med. 12(1), 29-38. https://doi.org/10.1111/jsm.12744

Gormemis AE, Ha TS, Im I (2005) Benzofuroindole analogues as potent BK (Ca) channel openers. 6(10), 1745-1748. https://doi.org/10.1002/cbic.200400448

J. Choi, J. Choi, G. Lee (2006) Acute toxicity of the BKCa channel opener LDD175 J Appl Pharmacol. 14, 253-258.

Kazuhiro Suzuki, Kazuto Ito, Takanori Suzuki, Hidetoshi Yamanaka, Seijiro Honma (1995) Synergistic effects of estrogen and androgen on the prostate: effects of estrogen on androgen- and estrogen-receptors, BrdU uptake, immunohistochemical study of AR, and responses to antiandrogens Prostate. 26(3), 151-163. https://doi.org/10.1002/pros.2990260307

Hitoshi Kontani, Chisato Shiraoya (2002) Method for simultaneous recording of the prostatic contractile and urethral pressure responses in anesthetized rats and the effects of tamsulosin Jpn J Pharmacol. 90(3), 281-290. https://doi.org/10.1254/jjp.90.281

Choi BR, Soni KK, Zhang LT (2016) Effect of 4- chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2- b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia Int J Urol. 23(3), 259-265. https://doi.org/10.1111/iju.13018

Alexander Opoku-Acheampong, Dave Unis, Jamie Henningson, Amanda Beck, Brian Lindshield (2013) Opoku-Acheampong AB, Unis D, Henningson JN, Beck AP, Lindshield BL. Preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice. 8(10), e77738. https://doi.org/10.1371/journal.pone.0077738

Acquaro Justulin LA Jr, Silva Carvalho RF, Felisbino SL (2010) Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology Int J Androl. 33(3), 489-499. https://doi.org/10.1111/j.1365-2605.2009.00963.x

Marco Marcelli, Glenn Cunningham (1999) Hormonal signaling in prostatic hyperplasia and neoplasia J Clin Endocrinol Metab. 84(10), 3463-3468. https://doi.org/10.1210/jcem.84.10.6083

Andriole G, Bruchovsky N, Chung LW (2004) DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. 172(4 Part 1), 1399-1403. https://doi.org/10.1097/01.ju.0000139539.94828.29

Additive Effect of Oral Tetradecanoic Acid to Tamsulosin and Finasteride in a Benign Prostatic Hyperplasia Rat Model

Published

2020-04-09

How to Cite

Additive Effect of Oral Tetradecanoic Acid to Tamsulosin and Finasteride in a Benign Prostatic Hyperplasia Rat Model. (2020). Global Journal of Medical Research, 20(21), 33-37. https://medicalresearchjournal.org/index.php/GJMR/article/view/2057